Screener
Assembly Biosciences ASMB Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest and other income, net | 2,291 | 1,123 |
| Total other income | 2,291 | 1,123 |
| Net loss | $(9,079) | $(8,818) |
| Other comprehensive loss | ||
| Unrealized loss on marketable securities | 327 | 42 |
| Comprehensive loss | $(9,406) | $(8,860) |
| Net loss per share, basic and diluted | $(0.54) | $(1.17) |
| Weighted average common shares outstanding, basic and diluted | 16,900,232 | 7,506,321 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's shares (diluted)?
- Assembly Biosciences (ASMB) reported shares (diluted) of 16.9M in Q1 2026.
- How has Assembly Biosciences's shares (diluted) changed year-over-year?
- Assembly Biosciences's shares (diluted) increased by 125.1% year-over-year, from 7.5M to 16.9M.
- What is the long-term trend for Assembly Biosciences's shares (diluted)?
- Over 4 years (2021 to 2025), Assembly Biosciences's shares (diluted) has grown at a -30.9% compound annual growth rate (CAGR), from 171.4M to 39.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Assembly Biosciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude